India, June 2 -- Shares of Bluejay Diagnostics, Inc. (BJDX) more than doubled after the company announced a strategic partnership with Argonaut Manufacturing Services to support the development and commercialization of its Symphony diagnostic platform.
The stock is currently trading at $4.46, up $2.29 or 105.53%, on the Nasdaq. It opened at $6.12 after closing the previous session at $2.17. The stock has traded between $1.62 and $16.68 over the past 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....